Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
about
Immunomodulatory effects of soluble CD5 on experimental tumor models.The clinical significance of CXCL5 in non-small cell lung cancer.EGFR-TKIs resistance via EGFR-independent signaling pathways.DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.The regulation of cytokine signaling by retinal determination gene network pathway in cancer
P2860
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@en
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@nl
type
label
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@en
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@nl
prefLabel
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@en
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@nl
P2093
P2860
P356
P1433
P1476
Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.
@en
P2093
Hanxiao Xu
Kongming Wu
Shengnan Yu
Xinwei Han
P2860
P304
1010428317712445
P356
10.1177/1010428317712445
P577
2017-06-01T00:00:00Z